A retrospective outcomes study 25-gauge 10,000 CPM beveled-tip and 25-gauge flat-tip microincision vitrectomy for proliferative diabetic retinopathy treatment

BackgroundTo evaluate the therapeutic efficacy and safety of 25-gauge (25G) 10,000 cpm (10K) beveled-tip microincision vitrectomy (MIVS) versus 25-gauge (25G) flat-tip MIVS in managing proliferative diabetic retinopathy (PDR).MethodsThis retrospective study involved 60 eyes with proliferative diabet...

Full description

Saved in:
Bibliographic Details
Main Authors: Guangjie Han, Jianwei Zhai, Hongbo Huang, Limei He, Heruo Wei, Lirong Wei, Huanyan Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1614668/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849222405142085632
author Guangjie Han
Jianwei Zhai
Hongbo Huang
Limei He
Heruo Wei
Lirong Wei
Huanyan Wang
author_facet Guangjie Han
Jianwei Zhai
Hongbo Huang
Limei He
Heruo Wei
Lirong Wei
Huanyan Wang
author_sort Guangjie Han
collection DOAJ
description BackgroundTo evaluate the therapeutic efficacy and safety of 25-gauge (25G) 10,000 cpm (10K) beveled-tip microincision vitrectomy (MIVS) versus 25-gauge (25G) flat-tip MIVS in managing proliferative diabetic retinopathy (PDR).MethodsThis retrospective study involved 60 eyes with proliferative diabetic retinopathy (PDR) from 60 patients, all requiring epiretinal membrane removal. The patients were assigned to either the 25G 10K cpm beveled-tip MIVS group or the 25G flat-tip MIVS group. Surgical outcomes, including membrane removal efficiency, vitrectomy probe (VP) and microforceps exchanges, total procedure duration, vitrectomy time, and intraoperative complications, were documented. Best-corrected visual acuity (BCVA), intraocular pressure (IOP), and postoperative complications were assessed during a 6-month follow-up period.ResultsFifty-eight eyes (from 58 patients) completed follow-up, including 30 eyes in the 25G 10K cpm beveled-tip group and 28 eyes in the 25G flat-tip group. During surgery, the 25G 10k cpm beveled-tip group demonstrated more effective membrane cutting (p = 0.001) and required fewer exchanges between the vitrectomy probe and microforceps (p = 0.001). The total surgery time and vitrectomy time were both reduced in this group (p = 0.001 and p = 0.001, respectively). Additionally, fewer intraoperative hemostasis maneuvers were needed in the 25G 10K cpm beveled-tip group. All follow-up outcomes indicated no significant differences between the two groups.ConclusionIn the surgical treatment of PDR, the 25G 10K cpm beveled-tip MIVS group showed no statistically significant difference compared to conventional 25G flat-tip MIVS in terms of visual acuity improvement and postoperative intraocular pressure. However, the former demonstrated advantages such as reduced surgical time, decreased intraoperative use of electrocoagulation, and fewer instrument exchanges within the eye, providing robust evidence for its efficacy in PDR surgical management.
format Article
id doaj-art-5745507f62d94c9a8ba1c9a658b6b79c
institution Kabale University
issn 2296-858X
language English
publishDate 2025-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj-art-5745507f62d94c9a8ba1c9a658b6b79c2025-08-26T05:28:13ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-08-011210.3389/fmed.2025.16146681614668A retrospective outcomes study 25-gauge 10,000 CPM beveled-tip and 25-gauge flat-tip microincision vitrectomy for proliferative diabetic retinopathy treatmentGuangjie HanJianwei ZhaiHongbo HuangLimei HeHeruo WeiLirong WeiHuanyan WangBackgroundTo evaluate the therapeutic efficacy and safety of 25-gauge (25G) 10,000 cpm (10K) beveled-tip microincision vitrectomy (MIVS) versus 25-gauge (25G) flat-tip MIVS in managing proliferative diabetic retinopathy (PDR).MethodsThis retrospective study involved 60 eyes with proliferative diabetic retinopathy (PDR) from 60 patients, all requiring epiretinal membrane removal. The patients were assigned to either the 25G 10K cpm beveled-tip MIVS group or the 25G flat-tip MIVS group. Surgical outcomes, including membrane removal efficiency, vitrectomy probe (VP) and microforceps exchanges, total procedure duration, vitrectomy time, and intraoperative complications, were documented. Best-corrected visual acuity (BCVA), intraocular pressure (IOP), and postoperative complications were assessed during a 6-month follow-up period.ResultsFifty-eight eyes (from 58 patients) completed follow-up, including 30 eyes in the 25G 10K cpm beveled-tip group and 28 eyes in the 25G flat-tip group. During surgery, the 25G 10k cpm beveled-tip group demonstrated more effective membrane cutting (p = 0.001) and required fewer exchanges between the vitrectomy probe and microforceps (p = 0.001). The total surgery time and vitrectomy time were both reduced in this group (p = 0.001 and p = 0.001, respectively). Additionally, fewer intraoperative hemostasis maneuvers were needed in the 25G 10K cpm beveled-tip group. All follow-up outcomes indicated no significant differences between the two groups.ConclusionIn the surgical treatment of PDR, the 25G 10K cpm beveled-tip MIVS group showed no statistically significant difference compared to conventional 25G flat-tip MIVS in terms of visual acuity improvement and postoperative intraocular pressure. However, the former demonstrated advantages such as reduced surgical time, decreased intraoperative use of electrocoagulation, and fewer instrument exchanges within the eye, providing robust evidence for its efficacy in PDR surgical management.https://www.frontiersin.org/articles/10.3389/fmed.2025.1614668/fullvitrectomyproliferative diabetic retinopathyvitreoretinal surgery25G flat-tip MIVS25G 10K cpm beveled-tip MIVS
spellingShingle Guangjie Han
Jianwei Zhai
Hongbo Huang
Limei He
Heruo Wei
Lirong Wei
Huanyan Wang
A retrospective outcomes study 25-gauge 10,000 CPM beveled-tip and 25-gauge flat-tip microincision vitrectomy for proliferative diabetic retinopathy treatment
Frontiers in Medicine
vitrectomy
proliferative diabetic retinopathy
vitreoretinal surgery
25G flat-tip MIVS
25G 10K cpm beveled-tip MIVS
title A retrospective outcomes study 25-gauge 10,000 CPM beveled-tip and 25-gauge flat-tip microincision vitrectomy for proliferative diabetic retinopathy treatment
title_full A retrospective outcomes study 25-gauge 10,000 CPM beveled-tip and 25-gauge flat-tip microincision vitrectomy for proliferative diabetic retinopathy treatment
title_fullStr A retrospective outcomes study 25-gauge 10,000 CPM beveled-tip and 25-gauge flat-tip microincision vitrectomy for proliferative diabetic retinopathy treatment
title_full_unstemmed A retrospective outcomes study 25-gauge 10,000 CPM beveled-tip and 25-gauge flat-tip microincision vitrectomy for proliferative diabetic retinopathy treatment
title_short A retrospective outcomes study 25-gauge 10,000 CPM beveled-tip and 25-gauge flat-tip microincision vitrectomy for proliferative diabetic retinopathy treatment
title_sort retrospective outcomes study 25 gauge 10 000 cpm beveled tip and 25 gauge flat tip microincision vitrectomy for proliferative diabetic retinopathy treatment
topic vitrectomy
proliferative diabetic retinopathy
vitreoretinal surgery
25G flat-tip MIVS
25G 10K cpm beveled-tip MIVS
url https://www.frontiersin.org/articles/10.3389/fmed.2025.1614668/full
work_keys_str_mv AT guangjiehan aretrospectiveoutcomesstudy25gauge10000cpmbeveledtipand25gaugeflattipmicroincisionvitrectomyforproliferativediabeticretinopathytreatment
AT jianweizhai aretrospectiveoutcomesstudy25gauge10000cpmbeveledtipand25gaugeflattipmicroincisionvitrectomyforproliferativediabeticretinopathytreatment
AT hongbohuang aretrospectiveoutcomesstudy25gauge10000cpmbeveledtipand25gaugeflattipmicroincisionvitrectomyforproliferativediabeticretinopathytreatment
AT limeihe aretrospectiveoutcomesstudy25gauge10000cpmbeveledtipand25gaugeflattipmicroincisionvitrectomyforproliferativediabeticretinopathytreatment
AT heruowei aretrospectiveoutcomesstudy25gauge10000cpmbeveledtipand25gaugeflattipmicroincisionvitrectomyforproliferativediabeticretinopathytreatment
AT lirongwei aretrospectiveoutcomesstudy25gauge10000cpmbeveledtipand25gaugeflattipmicroincisionvitrectomyforproliferativediabeticretinopathytreatment
AT huanyanwang aretrospectiveoutcomesstudy25gauge10000cpmbeveledtipand25gaugeflattipmicroincisionvitrectomyforproliferativediabeticretinopathytreatment
AT guangjiehan retrospectiveoutcomesstudy25gauge10000cpmbeveledtipand25gaugeflattipmicroincisionvitrectomyforproliferativediabeticretinopathytreatment
AT jianweizhai retrospectiveoutcomesstudy25gauge10000cpmbeveledtipand25gaugeflattipmicroincisionvitrectomyforproliferativediabeticretinopathytreatment
AT hongbohuang retrospectiveoutcomesstudy25gauge10000cpmbeveledtipand25gaugeflattipmicroincisionvitrectomyforproliferativediabeticretinopathytreatment
AT limeihe retrospectiveoutcomesstudy25gauge10000cpmbeveledtipand25gaugeflattipmicroincisionvitrectomyforproliferativediabeticretinopathytreatment
AT heruowei retrospectiveoutcomesstudy25gauge10000cpmbeveledtipand25gaugeflattipmicroincisionvitrectomyforproliferativediabeticretinopathytreatment
AT lirongwei retrospectiveoutcomesstudy25gauge10000cpmbeveledtipand25gaugeflattipmicroincisionvitrectomyforproliferativediabeticretinopathytreatment
AT huanyanwang retrospectiveoutcomesstudy25gauge10000cpmbeveledtipand25gaugeflattipmicroincisionvitrectomyforproliferativediabeticretinopathytreatment